- Report
- November 2021
- 108 Pages
Global
From €10859EUR$10,995USD£9,035GBP
- Clinical Trials
- November 2021
- 323 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- November 2021
- 64 Pages
Global
From €6909EUR$6,995USD£5,748GBP
- Report
- October 2021
- 57 Pages
Global
From €6909EUR$6,995USD£5,748GBP
- Report
- October 2021
- 54 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- June 2021
Global
From €10859EUR$10,995USD£9,035GBP
- Report
- November 2020
- 46 Pages
Global
From €3946EUR$3,995USD£3,283GBP
- Report
- September 2020
- 47 Pages
Global
From €3946EUR$3,995USD£3,283GBP
- Report
- February 2020
- 163 Pages
Global
From €10859EUR$10,995USD£9,035GBP
- Report
- February 2020
- 44 Pages
Asia Pacific
From €3452EUR$3,495USD£2,872GBP
- Report
- October 2019
- 128 Pages
Global
From €10859EUR$10,995USD£9,035GBP
- Report
- July 2019
- 31 Pages
Global
From €3946EUR$3,995USD£3,283GBP
- Report
- August 2022
United States
From €1916EUR$1,940USD£1,594GBP
- Report
- August 2022
United States
From €1916EUR$1,940USD£1,594GBP
- Report
- August 2022
United States
From €1916EUR$1,940USD£1,594GBP
- Report
- August 2022
United States
From €1916EUR$1,940USD£1,594GBP
- Report
- August 2022
United States
From €1916EUR$1,940USD£1,594GBP
- Report
- August 2022
United States
From €1916EUR$1,940USD£1,594GBP
- Report
- August 2022
Global
From €780EUR$790USD£649GBP
- Report
- August 2022
Global
From €780EUR$790USD£649GBP
The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more